📰 Benzinga Psychedelics News

Benzinga Psychedelics News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Benzinga Psychedelics. Real-time updates on events, politics, business and more.

Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors - SciSparc (NASDAQ:SPRC), Clearmind Medicine (NASDAQ:CMND)

March 12, 2024

Mark Haden Clearmind Medicine Adi Zuloff Shani Zuloff Shani Benzinga Psychedelics Alcohol Use Disorder

Source: benzinga.com

Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More - ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND)

January 27, 2024

New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian psychiatrists provide first psychedelic-assisted treatments in 50 years.

Clearmind Medicine Brandon Weiss David Nutt Incannex Healthcare Ted Cassidy Joel Latham

Source: benzinga.com

Podcast: International Cannabis And Psychedelics Co. Is Working 'Hand In Hand' With FDA To Forge New Therapy Frontiers - Incannex Healthcare (NASDAQ:IXHL)

January 25, 2024

Incannex Healthcare Joel Latham Australian Stock Exchange Benzinga Psychedelics

Source: benzinga.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Benzinga Psychedelics News Today

Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors - SciSparc (NASDAQ:SPRC), Clearmind Medicine (NASDAQ:CMND)

Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More - ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND)

Podcast: International Cannabis And Psychedelics Co. Is Working 'Hand In Hand' With FDA To Forge New Therapy Frontiers - Incannex Healthcare (NASDAQ:IXHL)

Explore More Categories